PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
26-Mar-2025 Blujepa (gepotidacin) approved by US FDA for treatment of uncomplicated urinary tract infections (uUTIs) in female adults and paediatric patients 12 years of age and older GSK
26-Mar-2025 Pleco Therapeutics Announces Positive Outcome of Pre-IND meeting with FDA for PTX-252 in Acute Myeloid Leukaemia Pleco Therapeutics
26-Mar-2025 ONWARD Medical Announces First-in-Human Use of ARC-IM Lumbar Lead Designed to Restore Standing, Stepping, and Lower Limb Mobility ONWARD Medical
26-Mar-2025 Chlamydia vaccine candidate granted fast track designation by the US FDA Sanofi
26-Mar-2025 Xcellbio Announces Partnership with Planet Innovation to Develop and Manufacture Next Generation Instruments to Improve potency for Rapid Cell Therapy Manufacturing Xcellbio
26-Mar-2025 iTeos to Present Preclinical Data on Potential Best-In-Class Anti-TREM2 Antibody, EOS-215, and Novel PTPN1/2 Inhibitor at the American Association for Cancer Research Annual Meeting 2025 iTeos Therapeutics
26-Mar-2025 FDA Issues Nyxoah an Approvable Letter for its Genio® System Nyxoah SA.
26-Mar-2025 Heidelberg Pharma to Present Data from its ADC Technology Platforms at AACR Annual Meeting 2025 Heidelberg Pharma AG
26-Mar-2025 BIOVERSYS REPORTS CORPORATE HIGHLIGHS AND KEY FINANCIALS FOR THE FULL YEAR 2024 BioVersys AG
25-Mar-2025 Resolutions of the Combined Annual Shareholders’ Meeting of Sartorius Stedim Biotech S.A. Sartorius Stedim Biotech SA
25-Mar-2025 ELRIG Announces Prof Rory Johnson and Dr Shalini Andersson as Keynote Speakers at Therapeutic Oligonucleotides 2025 ELRIG
25-Mar-2025 Nxera Pharma’s Partner Tempero Bio Initiates Phase 2 Trial with TMP-301 for Alcohol Use Disorder Nxera Pharma
25-Mar-2025 Allegro’s injectable osteoarthritis treatment generates positive safety results in preclinical studies Allegro
25-Mar-2025 Tolebrutinib regulatory submission accepted for priority review in the US for patients with multiple sclerosis Sanofi
25-Mar-2025 CARBOGEN AMCIS Secures GMP Certification After Successful ANSM Inspection for its Aseptic Drug Product Manufacturing Site CARBOGEN AMCIS
25-Mar-2025 PwC certifies KELES as first VC-firm to achieve SFDR Article 9 for digital health investment KELES
25-Mar-2025 Availability of the Q1 2025 Aide mémoire Sanofi
25-Mar-2025 Santhera to share latest on commercial rollout of AGAMREE® and future strategic priorities at Capital Markets Day Santhera Pharmaceuticals
25-Mar-2025 CAS announces the participants selected for the 2025 CAS Future Leaders program CAS
25-Mar-2025 WWF launches five-year partnership with GSK WWF